Category: Drug safety and pharmacovigilance

In this blog, you’ll explore into the importance and procedures of conducting Root Cause Analysis (RCA) in pharmacovigilance, accompanied by relevant references for deeper understanding.

Welcome to our informative pharmacovigilance blog, where we shed light on the distinction between suspected drugs and concomitant drugs. Gain a deeper understanding of the roles and implications of suspected drugs in post-marketing surveillance and adverse event reporting.

In this detailed blog, we delve into the specific aspects of the benefit-risk evaluation process, accompanied by a flow diagram illustrating the sequential steps for proper implementation.

In this comprehensive blog, where we provide a comprehensive overview of pharmacovigilance. Whether you’re new to the field or seeking a refresher, our blog is here to guide you through the basics of pharmacovigilance.

From this insightful blog, where you can learn all about action items and provide guidance on how to handle them promptly in various circumstances. By the end of this blog, you’ll have the knowledge to confidently address action items and drive progress.

In this pharmacovigilance blog, we will delve into the details of civil penalties, addressing any uncertainties regarding the amount of penalties for late submissions or the provision of misleading data. Take a moment to read and gain clarity through this blog. Happy reading!

Welcome to our informative pharmacovigilance blog, where we explore the significance of the country of incidence in ICSR (Individual Case Safety Report) case processing and its potential impact on the outcome of the case. Join in our journey through the world of pharmacovigilance.

Welcome to the next instalment of our blog series on case triage in pharmacovigilance, where we explore why triage is a crucial part of case processing. In this blog, we will provide you with a comprehensive understanding through the lens of triage.